ConSynance Therapeutics, Inc.

United States

ConSynance Therapeutics is a clinical-stage biopharmaceutical company developing precision-dosed therapies for rare central nervous system (CNS) disorders with substantial unmet need. Source (opens in a new tab)

Headquarters: US